Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma

NCT02011113

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Celgene Trial Site Nagoya, Aichi-ken, Japan
  • Celgene Trial Site Kamogawa, Chiba, Japan
  • Celgene Trial Site Fukuoka, Japan
  • Celgene Trial Site Hiroshima, Japan
View all 14 locations
View Trial Details
Completed

Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients

NCT02471820

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • General Hospital of Athens "G. Gennimatas" Athens, Attica, Greece
  • General Hospital of Athens "Alexandra" Athens, Attica, Greece
  • University General Hospital of Patras Pátrai, Patra, Greece
  • Theageneio Anticancer Hospital of Thessaloniki Thessaloniki, Greece
View Trial Details
Completed

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

NCT00900263

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Highlands Oncology Group - Springdale Bentonville, Arkansas, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
View all 69 locations
View Trial Details

Related conditions